- Home
- PEPG vs GEG Comparison
PEPG vs GEG Comparison
Compare PEPG & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- GEG
- Stock Information
- Founded
- PEPG 2018
- GEG 1994
- Country
- PEPG United States
- GEG United States
- Employees
- PEPG N/A
- GEG N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- GEG Computer Software: Prepackaged Software
- Sector
- PEPG Health Care
- GEG Technology
- Exchange
- PEPG Nasdaq
- GEG Nasdaq
- Market Cap
- PEPG 52.4M
- GEG 54.7M
- IPO Year
- PEPG 2022
- GEG N/A
- Fundamental
- Price
- PEPG $1.42
- GEG $2.15
- Analyst Decision
- PEPG Buy
- GEG
- Analyst Count
- PEPG 3
- GEG 0
- Target Price
- PEPG $7.67
- GEG N/A
- AVG Volume (30 Days)
- PEPG 216.6K
- GEG 20.6K
- Earning Date
- PEPG 05-08-2025
- GEG 05-07-2025
- Dividend Yield
- PEPG N/A
- GEG N/A
- EPS Growth
- PEPG N/A
- GEG N/A
- EPS
- PEPG N/A
- GEG N/A
- Revenue
- PEPG N/A
- GEG $19,626,000.00
- Revenue This Year
- PEPG N/A
- GEG N/A
- Revenue Next Year
- PEPG N/A
- GEG N/A
- P/E Ratio
- PEPG N/A
- GEG N/A
- Revenue Growth
- PEPG N/A
- GEG 64.34
- 52 Week Low
- PEPG $0.88
- GEG $1.70
- 52 Week High
- PEPG $19.30
- GEG $2.20
- Technical
- Relative Strength Index (RSI)
- PEPG 46.62
- GEG 67.52
- Support Level
- PEPG $1.35
- GEG $1.98
- Resistance Level
- PEPG $1.55
- GEG $2.20
- Average True Range (ATR)
- PEPG 0.15
- GEG 0.10
- MACD
- PEPG -0.00
- GEG 0.01
- Stochastic Oscillator
- PEPG 18.42
- GEG 82.79
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.